Review




Structured Review

Synthego Inc cd9 multi-guide rna probe1
HGSC and NK-92 cell lines were cocultured at a ratio of effector (NK-92) to target (HGSC cell line) of 1:1 for 6 h unless otherwise indicated . (A) Frequency of <t>CD9+</t> NK-92 cells after coculture with and without transwell (left panel). Mean and standard deviations for n = 4. Exemplary 2D flow plots for CD9+ NK-92 cells after coculture (right panel). (B) Extra- and intracellular CD9 protein expression absent from the NK-92 cells and present at high levels in the OVCAR4 cells. (C) Quantitative real-time PCR of FACS-purified CD9+ and CD9− NK-92 cells after coculture with OVCAR4 cells. Copy number (top plots), fold gene expression changes (bottom plots). CD9 were transcripts exclusive to OVCAR4 cells. Controls: CD45 (positive for NK-92, negative for OVCAR4) and E-cadherin (negative for NK-92, positive for OVCAR4). (D) Flow cytometry shows cytochalasin D partially inhibits trogocytosis from HGSC cell lines. (E) Transfer of CD9+ membrane fragments from OVCAR4 cells onto NK-92 cells. Cocultures between OVCAR4 cells pre-stained with fluorescent membrane dye PKH67 and NK-92 cells at different target:effector ratios. PKH67 frequencies (top histograms) and CD9 frequencies (bottom histograms). (F) Microscopy shows trogocytosis. OVCAR4 cells and NK-92 cells stained with PKH67 (green) and PKH26 (red), respectively; cocultured for 3 h; and stained with CD45 and CD9 antibodies. Images (from a Keyence BZ-X800 microscope) for cells grown in monoculture 20× and coculture 60×. NK-92 cells that acquired CD9 from OVCAR4 cells are indicated with white arrows. Images were enhanced for brightness and contrast to optimize the printed image.
Cd9 Multi Guide Rna Probe1, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd9+multi-guide+rna+probe1/cd9+multi+guide+rna+probe1/pmc08546503-94-0-6
Average 90 stars, based on 1 article reviews
cd9 multi-guide rna probe1 - by Bioz Stars, 2026-10
90/100 stars

Images

1) Product Images from "High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment"

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment

Journal: Cell reports

doi: 10.1016/j.celrep.2021.109632

HGSC and NK-92 cell lines were cocultured at a ratio of effector (NK-92) to target (HGSC cell line) of 1:1 for 6 h unless otherwise indicated . (A) Frequency of CD9+ NK-92 cells after coculture with and without transwell (left panel). Mean and standard deviations for n = 4. Exemplary 2D flow plots for CD9+ NK-92 cells after coculture (right panel). (B) Extra- and intracellular CD9 protein expression absent from the NK-92 cells and present at high levels in the OVCAR4 cells. (C) Quantitative real-time PCR of FACS-purified CD9+ and CD9− NK-92 cells after coculture with OVCAR4 cells. Copy number (top plots), fold gene expression changes (bottom plots). CD9 were transcripts exclusive to OVCAR4 cells. Controls: CD45 (positive for NK-92, negative for OVCAR4) and E-cadherin (negative for NK-92, positive for OVCAR4). (D) Flow cytometry shows cytochalasin D partially inhibits trogocytosis from HGSC cell lines. (E) Transfer of CD9+ membrane fragments from OVCAR4 cells onto NK-92 cells. Cocultures between OVCAR4 cells pre-stained with fluorescent membrane dye PKH67 and NK-92 cells at different target:effector ratios. PKH67 frequencies (top histograms) and CD9 frequencies (bottom histograms). (F) Microscopy shows trogocytosis. OVCAR4 cells and NK-92 cells stained with PKH67 (green) and PKH26 (red), respectively; cocultured for 3 h; and stained with CD45 and CD9 antibodies. Images (from a Keyence BZ-X800 microscope) for cells grown in monoculture 20× and coculture 60×. NK-92 cells that acquired CD9 from OVCAR4 cells are indicated with white arrows. Images were enhanced for brightness and contrast to optimize the printed image.
Figure Legend Snippet: HGSC and NK-92 cell lines were cocultured at a ratio of effector (NK-92) to target (HGSC cell line) of 1:1 for 6 h unless otherwise indicated . (A) Frequency of CD9+ NK-92 cells after coculture with and without transwell (left panel). Mean and standard deviations for n = 4. Exemplary 2D flow plots for CD9+ NK-92 cells after coculture (right panel). (B) Extra- and intracellular CD9 protein expression absent from the NK-92 cells and present at high levels in the OVCAR4 cells. (C) Quantitative real-time PCR of FACS-purified CD9+ and CD9− NK-92 cells after coculture with OVCAR4 cells. Copy number (top plots), fold gene expression changes (bottom plots). CD9 were transcripts exclusive to OVCAR4 cells. Controls: CD45 (positive for NK-92, negative for OVCAR4) and E-cadherin (negative for NK-92, positive for OVCAR4). (D) Flow cytometry shows cytochalasin D partially inhibits trogocytosis from HGSC cell lines. (E) Transfer of CD9+ membrane fragments from OVCAR4 cells onto NK-92 cells. Cocultures between OVCAR4 cells pre-stained with fluorescent membrane dye PKH67 and NK-92 cells at different target:effector ratios. PKH67 frequencies (top histograms) and CD9 frequencies (bottom histograms). (F) Microscopy shows trogocytosis. OVCAR4 cells and NK-92 cells stained with PKH67 (green) and PKH26 (red), respectively; cocultured for 3 h; and stained with CD45 and CD9 antibodies. Images (from a Keyence BZ-X800 microscope) for cells grown in monoculture 20× and coculture 60×. NK-92 cells that acquired CD9 from OVCAR4 cells are indicated with white arrows. Images were enhanced for brightness and contrast to optimize the printed image.

Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Purification, Gene Expression, Flow Cytometry, Membrane, Staining, Microscopy

(A) CD9 expression levels in 11 HGSC and 15 non-HGSC tumor cell lines . (B) Cell lines ranked by level of CD9 expression. Cell lines selected for coculture with NK-92 cells: HGSC (magenta) and non-HGSC with high levels of CD9 (green) and with lower levels of CD9 (yellow). (C) Representative flow plots showing frequency of CD9+ NK-92 cells after coculture with non-HGSC tumor cell lines. (D) Cytochalasin D partially inhibits CD9 trogocytosis from non-HGSC tumor cell lines. (E) CD9 trogocytosis by the NKL cell line and primary NK cells in peripheral blood mononuclear cells (PBMCs).
Figure Legend Snippet: (A) CD9 expression levels in 11 HGSC and 15 non-HGSC tumor cell lines . (B) Cell lines ranked by level of CD9 expression. Cell lines selected for coculture with NK-92 cells: HGSC (magenta) and non-HGSC with high levels of CD9 (green) and with lower levels of CD9 (yellow). (C) Representative flow plots showing frequency of CD9+ NK-92 cells after coculture with non-HGSC tumor cell lines. (D) Cytochalasin D partially inhibits CD9 trogocytosis from non-HGSC tumor cell lines. (E) CD9 trogocytosis by the NKL cell line and primary NK cells in peripheral blood mononuclear cells (PBMCs).

Techniques Used: Expressing

NK-92 cells were cocultured with HGSC cell lines (1:1) for 6 h, treated with brefeldin A/monensin and PMA/ionomycin or vehicle, and analyzed with the NK cell antibody panel (K562 cells as positive control) ( ; ). CD9+ and CD9− NK-92 cells were manually gated with CD45+. (A) Frequencies of CD9+ and CD9− NK-92 cells producing intracellular cytokines are indicated. Student’s two-tailed t test (also for B), showing statistically significant differences between CD9+ and CD9− NK-92 cells. *p ≤ 0.01, **p ≤ 0.001, ***p ≤ 0.0001, ****p ≤ 0.00001. (B) Levels of intracellular cytokines produced by CD9+ and CD9− NK-92 cells. CD9+ NK-92 cells produced lower levels of anti-tumor cytokines (see text). (C) Cytotoxicity, measured by the calcein release assay, was suppressed toward HGSC cell lines compared with K562 cells (positive control) . Student’s two-tailed t test (also for D and E). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (D) CD9+ NK-92 cells that underwent FACS after coculture have reduced cytotoxicity for HGSC cells compared with CD9− NK-92 cells. Statistical significance was determined with a two-tailed t test. *p ≤ 0.03, (*) p = 0.06. (E) CD9-blocking antibody significantly increased NK-92 cytotoxicity toward OVCAR4 cells. (F) CD9 CRISPR knockout in OVCAR4 cells significantly increased NK-92 cytotoxicity in coculture. UT, untreated; vehicle, nucleofector solution. Statistical significance was determined with a two-tailed t test. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (A–D) Mean of triplicates and (E and F) mean of quadruplicates with standard deviations.
Figure Legend Snippet: NK-92 cells were cocultured with HGSC cell lines (1:1) for 6 h, treated with brefeldin A/monensin and PMA/ionomycin or vehicle, and analyzed with the NK cell antibody panel (K562 cells as positive control) ( ; ). CD9+ and CD9− NK-92 cells were manually gated with CD45+. (A) Frequencies of CD9+ and CD9− NK-92 cells producing intracellular cytokines are indicated. Student’s two-tailed t test (also for B), showing statistically significant differences between CD9+ and CD9− NK-92 cells. *p ≤ 0.01, **p ≤ 0.001, ***p ≤ 0.0001, ****p ≤ 0.00001. (B) Levels of intracellular cytokines produced by CD9+ and CD9− NK-92 cells. CD9+ NK-92 cells produced lower levels of anti-tumor cytokines (see text). (C) Cytotoxicity, measured by the calcein release assay, was suppressed toward HGSC cell lines compared with K562 cells (positive control) . Student’s two-tailed t test (also for D and E). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (D) CD9+ NK-92 cells that underwent FACS after coculture have reduced cytotoxicity for HGSC cells compared with CD9− NK-92 cells. Statistical significance was determined with a two-tailed t test. *p ≤ 0.03, (*) p = 0.06. (E) CD9-blocking antibody significantly increased NK-92 cytotoxicity toward OVCAR4 cells. (F) CD9 CRISPR knockout in OVCAR4 cells significantly increased NK-92 cytotoxicity in coculture. UT, untreated; vehicle, nucleofector solution. Statistical significance was determined with a two-tailed t test. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (A–D) Mean of triplicates and (E and F) mean of quadruplicates with standard deviations.

Techniques Used: Positive Control, Two Tailed Test, Produced, Release Assay, Blocking Assay, CRISPR, Knock-Out

KEY RESOURCES TABLE
Figure Legend Snippet: KEY RESOURCES TABLE

Techniques Used: Purification, Recombinant, Staining, Blocking Assay, Electron Microscopy, Cell Stimulation, Membrane, Labeling, Conjugation Assay, RNAscope, Isolation, Reverse Transcription, Gene Expression, Gene Knockout, DNA Sequencing, Software, Cytometry, Real-time Polymerase Chain Reaction, Microscopy, Flow Cytometry

Related Articles

Expressing:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Real-time Polymerase Chain Reaction:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Purification:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Gene Expression:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Flow Cytometry:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Membrane:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Staining:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Microscopy:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Positive Control:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Two Tailed Test:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Produced:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Release Assay:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Blocking Assay:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

CRISPR:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Knock-Out:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Recombinant:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Electron Microscopy:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Cell Stimulation:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Labeling:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Conjugation Assay:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

RNAscope:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Isolation:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Reverse Transcription:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Gene Knockout:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

DNA Sequencing:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Software:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Cytometry:

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment
Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.



Similar Products

90
Synthego Inc cd9 multi-guide rna probe1
HGSC and NK-92 cell lines were cocultured at a ratio of effector (NK-92) to target (HGSC cell line) of 1:1 for 6 h unless otherwise indicated . (A) Frequency of <t>CD9+</t> NK-92 cells after coculture with and without transwell (left panel). Mean and standard deviations for n = 4. Exemplary 2D flow plots for CD9+ NK-92 cells after coculture (right panel). (B) Extra- and intracellular CD9 protein expression absent from the NK-92 cells and present at high levels in the OVCAR4 cells. (C) Quantitative real-time PCR of FACS-purified CD9+ and CD9− NK-92 cells after coculture with OVCAR4 cells. Copy number (top plots), fold gene expression changes (bottom plots). CD9 were transcripts exclusive to OVCAR4 cells. Controls: CD45 (positive for NK-92, negative for OVCAR4) and E-cadherin (negative for NK-92, positive for OVCAR4). (D) Flow cytometry shows cytochalasin D partially inhibits trogocytosis from HGSC cell lines. (E) Transfer of CD9+ membrane fragments from OVCAR4 cells onto NK-92 cells. Cocultures between OVCAR4 cells pre-stained with fluorescent membrane dye PKH67 and NK-92 cells at different target:effector ratios. PKH67 frequencies (top histograms) and CD9 frequencies (bottom histograms). (F) Microscopy shows trogocytosis. OVCAR4 cells and NK-92 cells stained with PKH67 (green) and PKH26 (red), respectively; cocultured for 3 h; and stained with CD45 and CD9 antibodies. Images (from a Keyence BZ-X800 microscope) for cells grown in monoculture 20× and coculture 60×. NK-92 cells that acquired CD9 from OVCAR4 cells are indicated with white arrows. Images were enhanced for brightness and contrast to optimize the printed image.
Cd9 Multi Guide Rna Probe1, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd9+multi-guide+rna+probe1/cd9+multi+guide+rna+probe1/pmc08546503-94-0-6
Average 90 stars, based on 1 article reviews
cd9 multi-guide rna probe1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


HGSC and NK-92 cell lines were cocultured at a ratio of effector (NK-92) to target (HGSC cell line) of 1:1 for 6 h unless otherwise indicated . (A) Frequency of CD9+ NK-92 cells after coculture with and without transwell (left panel). Mean and standard deviations for n = 4. Exemplary 2D flow plots for CD9+ NK-92 cells after coculture (right panel). (B) Extra- and intracellular CD9 protein expression absent from the NK-92 cells and present at high levels in the OVCAR4 cells. (C) Quantitative real-time PCR of FACS-purified CD9+ and CD9− NK-92 cells after coculture with OVCAR4 cells. Copy number (top plots), fold gene expression changes (bottom plots). CD9 were transcripts exclusive to OVCAR4 cells. Controls: CD45 (positive for NK-92, negative for OVCAR4) and E-cadherin (negative for NK-92, positive for OVCAR4). (D) Flow cytometry shows cytochalasin D partially inhibits trogocytosis from HGSC cell lines. (E) Transfer of CD9+ membrane fragments from OVCAR4 cells onto NK-92 cells. Cocultures between OVCAR4 cells pre-stained with fluorescent membrane dye PKH67 and NK-92 cells at different target:effector ratios. PKH67 frequencies (top histograms) and CD9 frequencies (bottom histograms). (F) Microscopy shows trogocytosis. OVCAR4 cells and NK-92 cells stained with PKH67 (green) and PKH26 (red), respectively; cocultured for 3 h; and stained with CD45 and CD9 antibodies. Images (from a Keyence BZ-X800 microscope) for cells grown in monoculture 20× and coculture 60×. NK-92 cells that acquired CD9 from OVCAR4 cells are indicated with white arrows. Images were enhanced for brightness and contrast to optimize the printed image.

Journal: Cell reports

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment

doi: 10.1016/j.celrep.2021.109632

Figure Lengend Snippet: HGSC and NK-92 cell lines were cocultured at a ratio of effector (NK-92) to target (HGSC cell line) of 1:1 for 6 h unless otherwise indicated . (A) Frequency of CD9+ NK-92 cells after coculture with and without transwell (left panel). Mean and standard deviations for n = 4. Exemplary 2D flow plots for CD9+ NK-92 cells after coculture (right panel). (B) Extra- and intracellular CD9 protein expression absent from the NK-92 cells and present at high levels in the OVCAR4 cells. (C) Quantitative real-time PCR of FACS-purified CD9+ and CD9− NK-92 cells after coculture with OVCAR4 cells. Copy number (top plots), fold gene expression changes (bottom plots). CD9 were transcripts exclusive to OVCAR4 cells. Controls: CD45 (positive for NK-92, negative for OVCAR4) and E-cadherin (negative for NK-92, positive for OVCAR4). (D) Flow cytometry shows cytochalasin D partially inhibits trogocytosis from HGSC cell lines. (E) Transfer of CD9+ membrane fragments from OVCAR4 cells onto NK-92 cells. Cocultures between OVCAR4 cells pre-stained with fluorescent membrane dye PKH67 and NK-92 cells at different target:effector ratios. PKH67 frequencies (top histograms) and CD9 frequencies (bottom histograms). (F) Microscopy shows trogocytosis. OVCAR4 cells and NK-92 cells stained with PKH67 (green) and PKH26 (red), respectively; cocultured for 3 h; and stained with CD45 and CD9 antibodies. Images (from a Keyence BZ-X800 microscope) for cells grown in monoculture 20× and coculture 60×. NK-92 cells that acquired CD9 from OVCAR4 cells are indicated with white arrows. Images were enhanced for brightness and contrast to optimize the printed image.

Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Techniques: Expressing, Real-time Polymerase Chain Reaction, Purification, Gene Expression, Flow Cytometry, Membrane, Staining, Microscopy

(A) CD9 expression levels in 11 HGSC and 15 non-HGSC tumor cell lines . (B) Cell lines ranked by level of CD9 expression. Cell lines selected for coculture with NK-92 cells: HGSC (magenta) and non-HGSC with high levels of CD9 (green) and with lower levels of CD9 (yellow). (C) Representative flow plots showing frequency of CD9+ NK-92 cells after coculture with non-HGSC tumor cell lines. (D) Cytochalasin D partially inhibits CD9 trogocytosis from non-HGSC tumor cell lines. (E) CD9 trogocytosis by the NKL cell line and primary NK cells in peripheral blood mononuclear cells (PBMCs).

Journal: Cell reports

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment

doi: 10.1016/j.celrep.2021.109632

Figure Lengend Snippet: (A) CD9 expression levels in 11 HGSC and 15 non-HGSC tumor cell lines . (B) Cell lines ranked by level of CD9 expression. Cell lines selected for coculture with NK-92 cells: HGSC (magenta) and non-HGSC with high levels of CD9 (green) and with lower levels of CD9 (yellow). (C) Representative flow plots showing frequency of CD9+ NK-92 cells after coculture with non-HGSC tumor cell lines. (D) Cytochalasin D partially inhibits CD9 trogocytosis from non-HGSC tumor cell lines. (E) CD9 trogocytosis by the NKL cell line and primary NK cells in peripheral blood mononuclear cells (PBMCs).

Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Techniques: Expressing

NK-92 cells were cocultured with HGSC cell lines (1:1) for 6 h, treated with brefeldin A/monensin and PMA/ionomycin or vehicle, and analyzed with the NK cell antibody panel (K562 cells as positive control) ( ; ). CD9+ and CD9− NK-92 cells were manually gated with CD45+. (A) Frequencies of CD9+ and CD9− NK-92 cells producing intracellular cytokines are indicated. Student’s two-tailed t test (also for B), showing statistically significant differences between CD9+ and CD9− NK-92 cells. *p ≤ 0.01, **p ≤ 0.001, ***p ≤ 0.0001, ****p ≤ 0.00001. (B) Levels of intracellular cytokines produced by CD9+ and CD9− NK-92 cells. CD9+ NK-92 cells produced lower levels of anti-tumor cytokines (see text). (C) Cytotoxicity, measured by the calcein release assay, was suppressed toward HGSC cell lines compared with K562 cells (positive control) . Student’s two-tailed t test (also for D and E). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (D) CD9+ NK-92 cells that underwent FACS after coculture have reduced cytotoxicity for HGSC cells compared with CD9− NK-92 cells. Statistical significance was determined with a two-tailed t test. *p ≤ 0.03, (*) p = 0.06. (E) CD9-blocking antibody significantly increased NK-92 cytotoxicity toward OVCAR4 cells. (F) CD9 CRISPR knockout in OVCAR4 cells significantly increased NK-92 cytotoxicity in coculture. UT, untreated; vehicle, nucleofector solution. Statistical significance was determined with a two-tailed t test. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (A–D) Mean of triplicates and (E and F) mean of quadruplicates with standard deviations.

Journal: Cell reports

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment

doi: 10.1016/j.celrep.2021.109632

Figure Lengend Snippet: NK-92 cells were cocultured with HGSC cell lines (1:1) for 6 h, treated with brefeldin A/monensin and PMA/ionomycin or vehicle, and analyzed with the NK cell antibody panel (K562 cells as positive control) ( ; ). CD9+ and CD9− NK-92 cells were manually gated with CD45+. (A) Frequencies of CD9+ and CD9− NK-92 cells producing intracellular cytokines are indicated. Student’s two-tailed t test (also for B), showing statistically significant differences between CD9+ and CD9− NK-92 cells. *p ≤ 0.01, **p ≤ 0.001, ***p ≤ 0.0001, ****p ≤ 0.00001. (B) Levels of intracellular cytokines produced by CD9+ and CD9− NK-92 cells. CD9+ NK-92 cells produced lower levels of anti-tumor cytokines (see text). (C) Cytotoxicity, measured by the calcein release assay, was suppressed toward HGSC cell lines compared with K562 cells (positive control) . Student’s two-tailed t test (also for D and E). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (D) CD9+ NK-92 cells that underwent FACS after coculture have reduced cytotoxicity for HGSC cells compared with CD9− NK-92 cells. Statistical significance was determined with a two-tailed t test. *p ≤ 0.03, (*) p = 0.06. (E) CD9-blocking antibody significantly increased NK-92 cytotoxicity toward OVCAR4 cells. (F) CD9 CRISPR knockout in OVCAR4 cells significantly increased NK-92 cytotoxicity in coculture. UT, untreated; vehicle, nucleofector solution. Statistical significance was determined with a two-tailed t test. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (A–D) Mean of triplicates and (E and F) mean of quadruplicates with standard deviations.

Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Techniques: Positive Control, Two Tailed Test, Produced, Release Assay, Blocking Assay, CRISPR, Knock-Out

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment

doi: 10.1016/j.celrep.2021.109632

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: CD9 multi-guide RNA probe2: CUUGGUUUUCAGCUUGUUGU , Synthego , N/A.

Techniques: Purification, Recombinant, Staining, Blocking Assay, Electron Microscopy, Cell Stimulation, Membrane, Labeling, Conjugation Assay, RNAscope, Isolation, Reverse Transcription, Gene Expression, Gene Knockout, DNA Sequencing, Software, Cytometry, Real-time Polymerase Chain Reaction, Microscopy, Flow Cytometry